-+ 0.00%
-+ 0.00%
-+ 0.00%

GRAIL EXEC EXPECTS BROAD LABEL FOR GALLERI CANCER TEST BASED OF DATA CO HAS SUBMITTED TO FDA- UBS HEALTHCARE CONFERENCE

Reuters·11/10/2026 16:10:40

Please log in to view news